These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11215836)

  • 21. Tourette's syndrome and treatment with clomipramine hydrochloride.
    Donahoe DH; Meador M; Fortune T; Llorena R
    W V Med J; 1991 Oct; 87(10):468-70. PubMed ID: 1767522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rebound withdrawal reactions due to clomipramine.
    Diamond BI; Borison RL; Katz R; DeVeaugh-Geiss J
    Psychopharmacol Bull; 1989; 25(2):209-12. PubMed ID: 2690164
    [No Abstract]   [Full Text] [Related]  

  • 23. Clomipramine in obsessional disorders: a cautionary tale.
    Morstyn R
    Aust N Z J Psychiatry; 1988 Jun; 22(2):190-4. PubMed ID: 3401188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rebound insomnia after abrupt clozapine withdrawal.
    Staedt J; Stoppe G; Hajak G; Ruther E
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(2):79-82. PubMed ID: 9063912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine.
    Biondi M; Fedele L; Arcangeli T; Pancheri P
    Psychother Psychosom; 1999; 68(2):111-2. PubMed ID: 10026463
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review.
    Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T
    East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depressive symptomatology during clozapine treatment: two case reports.
    Altamura AC; Bignotti S; Tura G; Curreli R; Pioli R
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):239-40. PubMed ID: 9716319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supersensitivity psychosis in a case with clozapine tolerance.
    Ozcan S; Soydan A; Tamam L
    Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reversible catatonia after the abrupt discontinuation of clozapine: Case report].
    Jaafari M; Bout A; Rammouz I; Aalouane R
    Encephale; 2016 Dec; 42(6):580-581. PubMed ID: 27644914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective serotonin reuptake inhibitor syndrome: precipitated by concomitant clozapine?
    Lu ML; Lane HY; Chang WH
    J Clin Psychopharmacol; 1999 Aug; 19(4):386-7. PubMed ID: 10440475
    [No Abstract]   [Full Text] [Related]  

  • 35. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases.
    Kim DD; Barr AM; Lu C; Stewart SE; White RF; Honer WG; Procyshyn RM
    Psychother Psychosom; 2020; 89(3):151-160. PubMed ID: 32045914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder.
    Galova A; Berney P; Desmeules J; Sergentanis I; Besson M
    BMC Psychiatry; 2019 Feb; 19(1):73. PubMed ID: 30782143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of clomipramine for obsessive-compulsive symptoms and chronic pain in two patients with schizophrenia.
    Kurokawa K; Tanino R
    J Clin Psychopharmacol; 1997 Aug; 17(4):329-30. PubMed ID: 9241021
    [No Abstract]   [Full Text] [Related]  

  • 39. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N; Tan LW; Wang Q; Li ZX; Li LJ
    Psychiatry Res; 2007 Feb; 150(1):61-9. PubMed ID: 17291595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.